The most common adverse events were gastrointestinal disorders ( @ patients -LSB- @ % -RSB- in the RO@ group vs seven -LSB- @ % -RSB- in the placebo group ) , and infections and infestations ( eight -LSB- @ % -RSB- vs nine -LSB- @ % -RSB- ) .